Hookipa Pharma Inc. Stock News

HOOKIPA Pharma Inc. (HOOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NEW YORK and VIENNA, Austria, Aug. 04, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases

NEW YORK and VIENNA, Austria, Aug. 03, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases

Royal Bank of Canada increased its position in Hookipa Pharma Inc (NASDAQ:HOOK) by 81.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,253 shares of the

A look at the shareholders of HOOKIPA Pharma Inc. (NASDAQ:HOOK) can tell us which group is most powerful. Institutions...

Dr. Anthony Fauci said Friday that the coronavirus has hit the U.S. "very severely" and the country "needs to get better control over things" in order to reopen the economy and head toward normality.

Steroid's COVID-19 benefits confirmed; spotlight on immune cells

Evelo Biosciences proceeds with midstage trial of EDP1815. HOOKIPA reports positive data for HB-101. Theratechnologies reports positive data.

HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today

US firms are ditching racist branding. But Ireland has had its share of offensive products

NEW YORK and VIENNA, Austria, June 19, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.

HOOKIPA Pharma Inc. (HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that the U.S.